{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-081880","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.625881+00:00","generated_at":"2026-05-19T22:22:34.595934+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AVITA Medical shareholders approve amended incentive plan, increase share reserve by 2.5M","bullets":["Amended 2020 Omnibus Incentive Plan approved, increasing share reserve by 2.5M to 6.75M shares.","All seven director nominees elected; for-votes ranged from 8.6M to 10.0M across candidates.","Ratified Grant Thornton as independent auditor for FY2025 with 13.4M votes for.","Approved grants to each of six non-executive directors: 10,022 RSUs and 4,295 options each.","Approved grant of options to acquire 520,000 shares to CEO James Corbett."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-081880","json":"https://secwatch.observer/filing/0000950170-25-081880.json","markdown":"https://secwatch.observer/filing/0000950170-25-081880.md","text":"https://secwatch.observer/filing/0000950170-25-081880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000095017025081880/0000950170-25-081880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000095017025081880/rcel-20250604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:22:34.595934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}